Fludarabine
Showing 2001 - 2025 of 2,127
Lymphoma Trial in Houston (Campath-1H, G-CSF, GM-CSF)
Chronic Lymphocytic Leukemia Trial in Leverkusen (bendamustine, Fludarabine)
Completed
- Chronic Lymphocytic Leukemia
- bendamustine
- Fludarabine
-
Leverkusen, NRW, GermanyProf. Dr. Norbert Niederle
Aug 24, 2011
Chronic Lymphocytic Leukemia Trial in Houston (Campath-1H)
Completed
- Chronic Lymphocytic Leukemia
-
Houston, TexasUT MD Anderson Cancer Center
Jul 27, 2012
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Cleveland (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +7 more
- anti-thymocyte globulin
- +4 more
-
Cleveland, OhioCase Medical Center, University Hospitals Seidman Cancer Center,
Dec 7, 2011
Leukemia Trial in Portland, Seattle, Leipzig (biological, drug, procedure, radiation)
Completed
- Leukemia
- therapeutic allogeneic lymphocytes
- +8 more
-
Portland, Oregon
- +2 more
Nov 28, 2011
MDS, Leukemia, Myeloid, Acute Trial in London (Fludarabine, Busulphan, Thymoglobuline (Anti-thymocyte globulin [rabbit]) -
Terminated
- Myelodysplastic Syndromes
- Leukemia, Myeloid, Acute
- Fludarabine
- +3 more
-
London, United KingdomKing's College Hospital NHS Foundation Trust
Aug 16, 2011
Myelodysplastic Syndrome, Leukemia Trial in Houston (Azacitidine)
Completed
- Myelodysplastic Syndrome
- Leukemia
-
Houston, TexasUT MD Anderson Cancer Center
Jul 27, 2012
Bone Marrow Failure, Osteopetrosis, Fanconi Anemia Trial in New York (Fludarabine, Cyclophosphamide, Cyclophosphamide 40)
Unknown status
- Bone Marrow Failure
- +3 more
- Fludarabine
- +3 more
-
New York, New YorkColumbia University Medical Center
Oct 18, 2011
Prostate Cancer Trial in Darlinghurst (Gene Directed Enzyme Prodrug Therapy, FP253/Fludarabine)
Unknown status
- Prostate Cancer
- Gene Directed Enzyme Prodrug Therapy, FP253/Fludarabine
-
Darlinghurst, New South Wales, AustraliaSt Vincent's Hospital, Sydney
Jul 8, 2011
Multiple Myeloma Trial in Germany (allogeneic stem cell transplant versus second autologous transplantation, RAD)
Completed
- Multiple Myeloma
- allogeneic stem cell transplant versus second autologous transplantation
- RAD
-
Berlin, Germany
- +11 more
Jun 27, 2012
Blood Samples to Evaluate Biomarkers of Donor Chimerism
Completed
- Leukemia
- +3 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
Feb 13, 2012
Multiple Myeloma Trial in Tehran (Autologous bone marrow transplantation, Allogeneic bone marrow transplantation)
Unknown status
- Multiple Myeloma
- Autologous bone marrow transplantation
- Allogeneic bone marrow transplantation
-
Tehran, Iran, Islamic Republic ofHematology-Oncology & SCT Research Center
May 31, 2012
Mucopolysaccharidosis Trial in Teharn (Conditioning regimen, Graft-versus-host disease (GVHD) prophylaxis, Stem Cell
Unknown status
- Mucopolysaccharidosis
- Conditioning regimen
- +2 more
-
Teharn, Tehran, Iran, Islamic Republic ofHematology-Oncology & SCT Research Center
May 31, 2012
Hematologic Malignancies Trial in Liege (Unmanipulated PBSC after nonmyeloablative conditioning, CD8-depleted PBSC after
Completed
- Hematologic Malignancies
- Unmanipulated PBSC after nonmyeloablative conditioning
- CD8-depleted PBSC after nonmyeloablative conditioning
-
Liege, BelgiumCHU Sart Tilman
Sep 1, 2011
Chronic Lymphocytic Leukemia Trial in Winnipeg (Valproic acid & fludarabine)
Terminated
- Chronic Lymphocytic Leukemia
- Valproic acid & fludarabine
-
Winnipeg, Manitoba, CanadaCancerCare Manitoba
Jul 18, 2011
Hematologic Malignancy, AML, ALL Trial in Boston (CD+8 T cell depletion)
Completed
- Hematologic Malignancy
- +6 more
- CD+8 T cell depletion
-
Boston, Massachusetts
- +1 more
Mar 15, 2012
Multiple Myeloma and Plasma Cell Tumor Trial in Marseille (biological, drug, procedure)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- anti-thymocyte globulin
- +4 more
-
Marseille, FranceMarseille Institute of Cancer - Institut J. Paoli and I. Calmett
May 13, 2011
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Marseille (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +5 more
- therapeutic immune globulin
- +3 more
-
Marseille, FranceMarseille Institute of Cancer - Institut J. Paoli and I. Calmett
May 14, 2011
GVHD, Hematologic Malignancies Trial in Boston (Sirolimus, Tacrolimus, Methotrexate)
Completed
- Graft Versus Host Disease
- Hematologic Malignancies
- Sirolimus
- +3 more
-
Boston, Massachusetts
- +2 more
Mar 6, 2012
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Jerusalem (Campath-1H /ATG)
Withdrawn
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Campath-1H /ATG
-
Jerusalem, IsraelHadassah Medical Organization
Apr 7, 2011
Hematological Tumors, Hematopoietic Stem Cell Transplantation Trial in Oklahoma City (Busulfex, Fludarabine, ALemtuzumab)
Completed
- Hematological Neoplasms
- Hematopoietic Stem Cell Transplantation
- Busulfex, Fludarabine, ALemtuzumab
-
Oklahoma City, OklahomaUniversity of Oklahoma Health Sciences Center
Mar 23, 2011
Leukemia, Myelodysplastic Syndrome Trial in Seoul (BuCy vs BuFlu)
Completed
- Leukemia
- Myelodysplastic Syndrome
- BuCy vs BuFlu
-
Seoul, Korea, Republic ofAsan Medical Center
Feb 10, 2011
Chronic Lymphocytic Leukemia, Lymphoma, Multiple Myeloma Trial in Seoul (Flu-Mel)
Completed
- Chronic Lymphocytic Leukemia
- +2 more
-
Seoul, Korea, Republic ofAsan Medical Center
Feb 16, 2011
Acute Myeloid Leukemia Trial in Memphis (drug, procedure, radiation)
Completed
- Acute Myeloid Leukemia
- Fludarabine, Cytarabine, Liposomal daunorubicin (DaunoXome)
- +3 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 5, 2011